Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Principal Investigator
Name
Omar Abdel-Rahman
Degrees
MD
Institution
Avicenna Oncology center
Position Title
Consultant and scientific director
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-417
Initial CDAS Request Approval
Nov 2, 2018
Title
Predictors of second primary cancers among patients diagnosed with lung cancer in the PLCO trial
Summary
A number of etiological factors which contribute to the development of lung cancer (e.g. smoking) might also predispose to the development of second primary cancers. Previous studies evaluating this research question were based on restrospectove registry-based analyses (e.g. SEER database). It is important to try to answer the same question in the context of prospectively collected dataset (like the PLCO trial dataset).
Aims

1. To determine the frequency of second primary cancers commonly developing among patients initially diagnosed with lung cancer.
2. To determine the factors associated with a higher risk of second primary malignancy development.

Collaborators

Dr. Omar Abdel-Rahman

Related Publications